Evidence map›Paper›PMID 30312291›Full record

ArticlePLoS genetics2018

Genome amplification and cellular senescence are hallmarks of human placenta development.

Philipp Velicky, Gudrun Meinhardt, Kerstin Plessl, Sigrid Vondra, Tamara Weiss, Peter Haslinger, Thomas Lendl, Karin Aumayr, Mario Mairhofer, Xiaowei Zhu and 13 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Epidermal growth factor receptor in placental health and disease: pathways, dysfunction, and chemical disruption.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  12. The multifaceted roles of the transcriptional coactivator TAZ in extravillous trophoblast development of the human placenta.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 3 countries.

Philipp VelickyDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-2340-7431
Gudrun MeinhardtDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.
Kerstin PlesslDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.
Sigrid VondraDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-0206-8319
Tamara WeissChildren's Cancer Research Institute, St. Anna Children´s Hospital, Vienna, Austria.
Peter HaslingerDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.
Thomas LendlBiooptics Facility of Institute of Molecular Pathology, Institute of Molecular Biotechnology and Gregor Mendel Institute, Vienna, Austria.
Karin AumayrBiooptics Facility of Institute of Molecular Pathology, Institute of Molecular Biotechnology and Gregor Mendel Institute, Vienna, Austria.
Mario MairhoferDepartment of Gynecological Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-7218-6284
Xiaowei ZhuDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-5731-3177
Birgit SchützCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-8604-309X
Roberta L HannibalDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0002-3219-4554
Robert LindauDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.ORCID 0000-0002-1255-7098
Beatrix WeilCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Jan ErnerudhDepartment of Clinical Immunology and Transfusion Medicine, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.ORCID 0000-0001-9456-2044
Jürgen NeesenCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-3635-2097
Gerda EggerClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2489-155X
Mario MikulaCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Clemens RöhrlCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Alexander E UrbanDepartment of Psychiatry and Behavioral Sciences, Department of Genetics, Stanford University School of Medicine, Tasha and John Morgridge Faculty Scholar, Stanford Child Health Research Institute, Stanford, California, United States of America.
Julie BakerDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Martin KnöflerDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6625-8950
Jürgen PollheimerDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-8440-5221
Medical University of Vienna · ATStanford University · USInstitute of Molecular Biotechnology · ATLinköping University · SESt Anna Children's Hospital · AT

Funding

Austrian Science Fund FWF P 28417Austrian Science Fund FWF P 31470
6 · The paper itself

Abstract

Genome amplification and cellular senescence are commonly associated with pathological processes. While physiological roles for polyploidization and senescence have been described in mouse development, controversy exists over their significance in humans. Here, we describe tetraploidization and senescence as phenomena of normal human placenta development. During pregnancy, placental extravillous trophoblasts (EVTs) invade the pregnant endometrium, termed decidua, to establish an adapted microenvironment required for the developing embryo. This process is critically dependent on continuous cell proliferation and differentiation, which is thought to follow the classical model of cell cycle arrest prior to terminal differentiation. Strikingly, flow cytometry and DNAseq revealed that EVT formation is accompanied with a genome-wide polyploidization, independent of mitotic cycles. DNA replication in these cells was analysed by a fluorescent cell-cycle indicator reporter system, cell cycle marker expression and EdU incorporation. Upon invasion into the decidua, EVTs widely lose their replicative potential and enter a senescent state characterized by high senescence-associated (SA) β-galactosidase activity, induction of a SA secretory phenotype as well as typical metabolic alterations. Furthermore, we show that the shift from endocycle-dependent genome amplification to growth arrest is disturbed in androgenic complete hydatidiform moles (CHM), a hyperplastic pregnancy disorder associated with increased risk of developing choriocarinoma. Senescence is decreased in CHM-EVTs, accompanied by exacerbated endoreduplication and hyperploidy. We propose induction of cellular senescence as a ploidy-limiting mechanism during normal human placentation and unravel a link between excessive polyploidization and reduced senescence in CHM.

Indexed as

Cell CycleCell Cycle CheckpointsCell DifferentiationCell MovementCell ProliferationCellular SenescenceEndometriumFemaleGenomeHumansPlacentaPlacentationPolyploidyPregnancyPregnancy Trimester, FirstPrimary Cell Culture

Identifiers

PMID30312291
PMCPMC6200260
OpenAlexW2897165876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.